ReviewTherapeutic advances in chronic disease2016

Mepolizumab for severe refractory eosinophilic asthma: evidence to date and clinical potential.

Francesco Menzella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.